Medicare Enrolled
Dr. Michael Fumo, M.D.
Urology Physician · Rockford, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fumo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fumo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fumo
Dr. Michael Fumo is an urology physician in Rockford, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fumo performed 5,163 Medicare services across 2,486 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fumo received a total of $6,664 from 51 pharmaceutical and/or device companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fumo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 23% volume in IL
$6,664 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,163
Medicare services
Top 23% in IL for urology physician
2,486
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~272 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 1,680 | $63 | $200 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
743 | $2 | $31 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
430 | $8 | $28 |
| PSA test (prostate cancer screening) | 424 | $18 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
319 | $88 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $60 | $175 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 306 | $136 | $1,033 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
165 | $7 | $192 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
100 | $24 | $130 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
97 | $174 | $590 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
82 | $36 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $123 | $375 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
50 | $9 | $41 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
43 | $104 | $478 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
42 | $163 | $561 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
42 | $45 | $490 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
41 | $41 | $100 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
39 | $15 | $83 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
38 | $42 | $246 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
26 | $111 | $2,046 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
25 | $68 | $130 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $80 | $280 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $104 | $366 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
22 | $40 | $126 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $138 | $459 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
8.6% medium
90.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,664
Total received (2018-2024)
Avg $952/year across 7 years
Top 26% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
347
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,417 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$247 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,235
2023
$1,293
2022
$1,114
2021
$648
2020
$312
2019
$1,108
2018
$955
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$164
AstraZeneca Pharmaceuticals LP
$144
Janssen Biotech, Inc.
$133
Astellas Pharma US Inc
$115
Teleflex LLC
$105
Bayer Healthcare Pharmaceuticals Inc.
$95
Dendreon Pharmaceuticals LLC
$85
ABBVIE INC.
$72
Tolmar, Inc.
$56
Merck Sharp & Dohme LLC
$55
Tempus AI, Inc
$50
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
Boston Scientific Corporation
$35
Verity Pharmaceuticals Inc.
$34
COLOPLAST CORP
$19
Endo USA, Inc.
$17
ACCORD HEALTHCARE, INC.
$16
Top 3 companies account for 35.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$944
Dendreon Pharmaceuticals LLC
$809
Janssen Biotech, Inc.
$570
Sumitomo Pharma America, Inc.
$474
AstraZeneca Pharmaceuticals LP
$323
Ferring Pharmaceuticals Inc.
$249
PFIZER INC.
$248
Bayer Healthcare Pharmaceuticals Inc.
$211
Bayer HealthCare Pharmaceuticals Inc.
$196
ABBVIE INC.
$192
Myovant Sciences Inc.
$182
Verity Pharmaceuticals Inc.
$162
Teleflex LLC
$158
Amgen Inc.
$147
Coloplast Corp
$146
AbbVie, Inc.
$134
Merck Sharp & Dohme LLC
$103
SANOFI-AVENTIS U.S. LLC
$100
Boston Scientific Corporation
$96
NeoTract Inc.
$85
Retrophin, Inc.
$76
Endo Pharmaceuticals Inc.
$67
TOLMAR Pharmaceuticals, Inc.
$66
Olympus America Inc.
$64
Rochester Medical Corporation
$61
Tolmar, Inc.
$56
AbbVie Inc.
$52
Tempus AI, Inc
$50
AngioDynamics, Inc.
$49
COLOPLAST CORP
$47
Antares Pharma, Inc.
$47
Travere Therapeutics, Inc.
$45
180 Medical, Inc.
$41
Progenics Pharmaceuticals, Inc.
$41
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
Blue Earth Diagnostics Limited
$38
Cook Medical LLC
$30
Allergan Inc.
$30
MEDIVATION FIELD SOLUTIONS LLC
$29
Medtronic, Inc.
$25
BOSTON SCIENTIFIC CORPORATION
$24
GENZYME CORPORATION
$21
UROGEN PHARMA, INC.
$18
Accord Healthcare, Inc.
$17
Endo USA, Inc.
$17
PROCEPT BioRobotics Corporation
$16
ACCORD HEALTHCARE, INC.
$16
Telix Pharmaceuticals
$13
DENTSPLY IH Inc.
$13
Shire North American Group Inc
$12
ConvaTec Inc.
$11
Top 3 companies account for 34.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS 800 Artificial Urinary Sphincter · AQUABEAM ROBOTIC SYSTEM · Androgel · Axumin · BOTOX · CAMCEVI · Cook Medical Biopsy · Dornier Medilas H Solvo · ELIGARD · ERLEADA · Erleada · FIRMAGON · GATTEX · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GREENLIGHT · GentleCath · ILLUCCIX · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Luja Coude · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Nubeqa · ORGOVYX · PROVENGE · PYLARIFY · Porges Coloplast · Prolia · REZUM · ROADRUNNER · SPEEDICATH · SpeediCath · TOVIAZ · Trelstar · UROLIFT · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
17
Per 100K population
6.0
County median income
$64,363
Nearest hospital
SAINT ANTHONY MEDICAL CENTER
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fumo is a clinical cardiology specialist, with above-average Medicare volume (top 23% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fumo experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Fumo performed 1,680 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fumo receive payments from pharmaceutical companies?
Yes. Dr. Fumo received a total of $6,664 from 51 companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fumo's costs compare to other urology physicians in Rockford?
Dr. Fumo's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fumo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Rockford
Browse urology physicians in Rockford ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology